# Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension

> **NCT01520207** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 52 (actual)

## Conditions studied

- Intra-dialytic Hypotension

## Interventions

- **DRUG:** Mannitol (20%)
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT01520207
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2016-07
- **Final completion:** 2018-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520207, "Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01520207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*